Tag: Hatch-Waxman Act
FDA Safety Alerts: Understanding Generic Drug Risks and Labeling Gaps
Explore how FDA safety alerts handle generic drug risks, the labeling gaps caused by the Hatch-Waxman Act, and the ongoing debate over the CBE-0 process for faster warning updates.
Patent Term Restoration: How Pharmaceutical Companies Legally Extend Drug Exclusivity
Patent term restoration lets pharmaceutical companies recover lost patent time due to FDA approval delays. Learn how the Hatch-Waxman Act enables up to 5 years of extra exclusivity and why it's critical for drug development.
About
Medications